Literature DB >> 20488357

Management of acquired bleeding problems in cancer patients.

Thomas G DeLoughery1.   

Abstract

Cancer patients can have acquired bleeding problems for many reasons. In this review, an approach to the evaluation and management of the bleeding patient is discussed. Specific issues including coagulation defects, thrombocytopenia, platelet dysfunction, and bleeding complications of specific hematological malignancies due to anticoagulation, are discussed. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Year:  2010        PMID: 20488357     DOI: 10.1016/j.hoc.2010.03.008

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  2 in total

1.  Recombinant activated factor VII as an additional agent in the management of bleeding in patients with chemotherapy-induced thrombocytopenia.

Authors:  Pavol Hollý; Lenka Lisá; Ivana Plameňová; Miroslava Dobrotová; Peter Kubisz
Journal:  Blood Transfus       Date:  2012-12-06       Impact factor: 3.443

2.  Benefits of Thromboelastography and Thrombin Generation Assay for Bleeding Prediction in Patients With Thrombocytopenia or Hematologic Malignancies.

Authors:  Seon Young Kim; Ja Yoon Gu; Hyun Ju Yoo; Ji Eun Kim; Seonpyo Jang; Sooyeon Choe; Youngil Koh; Inho Kim; Hyun Kyung Kim
Journal:  Ann Lab Med       Date:  2017-11       Impact factor: 3.464

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.